002287:SZSETibet Cheezheng Tibetan Medicine Co., Ltd. Analysis
Data as of 2026-03-07 - not real-time
CN¥24.97
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Tibet Cheezheng Tibetan Medicine Co., Ltd. trades at CNY 24.97, just above its 20‑day SMA (24.55) and 50‑day SMA (24.39), suggesting a slight technical edge. The RSI sits at 54, indicating neutral momentum, while the MACD histogram is positive and the signal line is bullish, reinforced by an increasing volume trend. With a beta of 0.20, the stock shows limited market‑wide volatility despite a 30‑day price volatility of over 25%.
Valuation appears attractive: the trailing PE of 21.7 is below the industry average of 25.1, the price‑to‑book ratio is 2.96, and the dividend yield of 2.4% comes with a 52% payout ratio, supported by a strong cash position (~CNY 3.0 bn) and moderate leverage (debt‑to‑equity ~20%). Operating margins are robust at 45% and ROE stands at 14%, offsetting modest revenue growth of 3.1%.
Valuation appears attractive: the trailing PE of 21.7 is below the industry average of 25.1, the price‑to‑book ratio is 2.96, and the dividend yield of 2.4% comes with a 52% payout ratio, supported by a strong cash position (~CNY 3.0 bn) and moderate leverage (debt‑to‑equity ~20%). Operating margins are robust at 45% and ROE stands at 14%, offsetting modest revenue growth of 3.1%.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and rising volume
- Neutral RSI indicating no overbought pressure
- Attractive dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued PE relative to industry
- Strong operating margins and ROE
- Sustainable dividend supporting total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low beta and stable cash base
- Consistent dividend income
- Potential upside as biotech sector matures
Key Metrics & Analysis
Financial Health
Revenue Growth3.10%
Profit Margin26.75%
P/E Ratio21.7
ROE14.42%
Debt/Equity20.35
P/B Ratio3.0
Op. Cash FlowCN¥0
Free Cash FlowCN¥0
Industry P/E25.1
Technical Analysis
TrendNeutral
RSI54.2
SupportCN¥23.32
ResistanceCN¥25.99
MA 20CN¥24.55
MA 50CN¥24.39
MA 200CN¥25.36
MACDBullish
VolumeIncreasing
Fear & Greed Index68.77
Valuation
Target PriceCN¥0.00
GradeUndervalued
TypeBlend
Dividend Yield2.40%
Risk Assessment
Beta0.29
Volatility25.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.